95639 ⎘
Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups , or - in which the condensed system contains four or more hetero rings
LURBINECTEDIN CRYSTAL FORM AND METHOD FOR PREPARING SAME
#2MACROCYCLIC COMPOUNDS, COMPOSITIONS, AND METHODS OF USING THEREOF
#3MACROCYCLIC COMPOUNDS, COMPOSITIONS, AND METHODS OF USING THEREOF
#4MACROCYCLE COMPOUNDS USEFUL AS KRAS INHIBITORS
#5MACROCYCLIC COMPOUNDS, COMPOSITIONS, AND METHODS OF USING THEREOF
#6MACROCYCLIC COMPOUNDS, COMPOSITIONS, AND METHODS OF USING THEREOF
#7PARTHENOLIDE DERIVATIVES AND USE THEREOF
#8BRIDGED TRICYCLIC CARBAMOYLPYRIDONE COMPOUNDS AND USES THEREOF
#9IMPROVED PROCESS FOR THE PREPARATION OF LURBINECTEDIN AND ITS MORPHS THEREOF
#10AZAINDAZOLE MACROCYCLE COMPOUNDS AND USES THEREOF
#11Modulators of Cystic Fibrosis Transmembrane Conductance Regulator, Pharmaceutical Compositions, Methods of Treatment, and Process for Making the Modulators
#12NOVEL CRYSTALLINE POLYMORPH OF LURBINECTEDIN AND IMPROVED PROCESS FOR THE PREPARATION OF LURBINECTEDIN
#13AN IMPROVED PROCESS FOR THE PREPARATION OF TRABECTEDIN
#14ANTITUMORAL COMPOUNDS
#15COVALENT EGFR INHIBITORS AND METHODS OF USE THEREOF
#16DRUG ANTIBODY CONJUGATES
#17LYOPHILIZED PHARMACEUTICAL COMPOSITION AND USES OF A CRYSTALLIZED FORM OF LURBINECTEDIN
#18MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR
#19CRYSTALLIZED FORM OF LURBINECTEDIN AND METHOD OF MAKING THE SAME
#20A LYOPHILIZED PHARMACEUTICAL COMPOSITION
#21Bridged tricyclic carbamoylpyridone compounds and uses thereof
#22Bridged tricyclic carbamoylpyridone compounds and uses thereof
#23MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES
#24MACROCYCLIC 7-PYRAZOL-5-YL-INDOLE DERIVATIVES AS INHIBITORS OF MCL-1
#25MACROCYCLIC ETHER CONTAINING INDOLE DERIVATIVES AS INHIBITORS OF MCL-1
#26N-LINKED MACROCYCLIC 7-(PYRAZOL-5-YL)-INDOLE DERIVATIVES AS INHIBIORS OF MCL-1
#27N-LINKED MACROCYCLIC 4-(PYRAZOL-5-YL)-INDOLE DERIVATIVES AS INHIBITORS OF MCL-1
#28Noscapinoid-producing Microbes and Methods of Making and Using the Same
#29MACROCYCLIC COMPOUNDS
#30Modulators of Alpha-4-beta-7 Integrin and MAdCAM
#31MACROCYCLIC INDOLE DERIVATIVES AS INHIBITORS OF MCL-1
#32COMPOUNDS
#33MACROCYLIC SULFONYL DERIVATIVES MCL-1 INHIBITORS
#34MACROCYLIC INDOLE DERIVATIVES MCL-1 INHIBITORS
#35NEW SOLID STATE FORM OF LURBINECTEDIN
#36Macrocyclic fused pyrazoles as Mcl-1 inhibitors
#37MACROCYCLIC SULFONYLAMIDE DERIVATIVES USEFUL AS NLRP3 INHIBITORS
#38Macrocyclic indoles as Mcl-1 inhibitors
#39IMPROVED PROCESS FOR THE PREPARATON OF PURE (1'R,6R,6aR,7R,13S,14S,16R)-5-(ACETYLOXY)-3',4',6,6a,7,13,14,16-OCTAHYDRO-6',8,14-TRIHYDROXY-7',9-DIMETHOXY-4,10,23-TRIMETHYLSPIRO[6,16-(EPITHIOPROPANOXYMETH ANO)-7,13-IMINO-12H-1,3-DIOXOLO[7,8]ISOQUINO[3,2-b][3]BENZAZOCINE-20,1'(2'H)-ISOQUINOLIN]-19-ONE POLYMORPH THERE OF
#40MACROCYCLIC INHIBITORS OF MCL-1
#41MACROCYCLIC SULFONYLUREA DERIVATIVES USEFUL AS NLRP3 INHIBITORS
#42Antitumoral compounds
#43HETEROCYCLIC COMPOUNDS AS INHIBITORS OF KRAS G12C
#44MACROCYCLIC COMPOUNDS
#45Modulators of Cystic Fibrosis Transmembrane Conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulators
#46INDOLE MACROCYCLIC DERIVATIVE, PREPARATION METHOD THEREOF AND APPLICATION THEREOF IN MEDICINE
#47Preparation method for ecteinascidin compound and intermediate thereof
#48Antitumoral compounds
#49Mcl-1 inhibitors and methods of use thereof
#50Preparation for natural product trabectedin
#51Antitumoral compounds
#52Modulators of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulators
#53MCL-1 inhibitors and methods of use thereof
#54Antitumoral compounds
#55MCL-1 inhibitors and methods of use thereof
#56NOSCAPINOID-PRODUCING MICROBES AND METHODS OF MAKING AND USING THE SAME
#57Benzothiazole macrocycles as inhibitors of human immunodeficiency virus replication
#58Macrocyclic compounds as protein kinase inhibitors
#59Inhibitors of human immunodeficiency virus replication
#60Tricyclic Gyrase inhibitors
#61Conformationally constrained, fully synthetic macrocyclic compounds
#62Macrocyclic compounds as protein kinase inhibitors
#63Polymer compound and electronic device using the same
#64Cyclic amides
#65Synthetic process for the manufacture of ecteinascidin compounds
#66Green Chemical Process to Produce Natural Products
#67Synthesis of naturally occuring ecteinascidins and related compounds
#68Antitumoral derivatives of ET-743
#69Difluoromethyl-containing macrocyclic compounds as hepatitis C virus inhibitors
#70Ecteinascidins
#71Pyridazinone derivatives useful as glucan synthase inhibitors
#72Synthesis of naturally occurring ecteinascidins and related compounds
#73Novel quinoxalinone derivatives
#74DEUTERIUM-ENRICHED TRABECTEDIN
#75Therapeutic compounds
#76Ecteinascidins
#77Anititumoral ecteinascidin derivatives
#78Antibiotic compounds
#79Hemisynthetic method and new compounds
#801,3,5-Triazines for Treatment of Viral Diseases
#811,3,5-triazines for treatment of viral diseases
#82Synthesis of naturally occurring ecteinascidins and related compounds
#83Ecteinascidin analogs for use as antitumour agents
#84Synthetic process for the manufacture of an ecteinaschidin compound
#85Antitumoral derivatives of ET-743
#86Ecteinascidins
#87Quinoxalinone derivatives
#88Metabolites of ecteinascidin 743